Nasekomo has appointed Svetlin Aleksandrov as its new Chief Financial Officer. Aleksandrov will be responsible for financial planning, risk management and legal coordination, and will be actively involved in the company’s strategic projects.
The Bulgarian biotech company for sustainable proteins and innovative bioconversion solutions, Nasekomo has a new Chief Financial Officer – Svetlin Aleksandrov. The company stated that Aleksandrov joins Nasekomo at a key stage in its development. The attraction of Svetlin Aleksandrov is intended to provide financial stability to the company in achieving its strategic development goals through an extensive cross-national franchise network.
Svetlin Aleksandrov joins Nasekomo from Danfoss, where he was Managing Partner for Bulgaria and Hungary with responsibility for finance and administration, in parallel responsible for the relevant strategies and operations for the Adriatic and Black Sea regions.
As Nasekomo’s Chief Financial Officer, Aleksandrov will be responsible for financial planning, risk management and legal coordination and will be actively involved in the company’s strategic projects.
“Svetlin’s expertise and leadership come at a time when we are strengthening our position on the market and preparing to introduce additional innovative solutions in 2025. I believe his expertise and skills will contribute to greater efficiency and align our operations with our ambitious growth vision,” said Marc Bolard, Nasekomo co-founder and co-CEO.
“I am very pleased to join the Nasekomo team. The company’s mission, the enthusiasm and the dedication of everyone here not only impresses but also motivates me to higher excellence and results. I believe that with my experience and knowledge I will help to achieve Nasekomo’s ambitious strategic goals in the short and long term,” expressed Svetlin Aleksandrov.
Earlier this year, Nasekomo secured €8 million Euro in Series A funding to establish and expand a network of franchise bioconversion factories across Europe, first of which will be in Bulgaria. Nasekomo explains it is actively investing in the digitalization and optimization of production processes through machine learning and artificial intelligence and is working on creating digital twins of future bioconversion factories.
